Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. - Test2 - elhamkhani - TriplyDB

Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.

Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.

http://www.wikidata.org/entity/Q34638268

about

Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis Neoadjuvant therapy for gastroesophageal adenocarcinoma Current adjuvant treatment modalities for gastric cancer: From history to the future Upgrading the definition of early gastric cancer: better staging means more appropriate treatment Personalized medicine in gastric cancer: Where are we and where are we going?Advanced gastric cancer: What we know and what we still have to learn Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer Emerging role of S-1 in gastric cancer Neoadjuvant therapy for gastric cancer: current evidence and future directions Neoadjuvant or adjuvant therapy for gastric cancer Subtotal gastrectomy for gastric cancer Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward Adjuvant therapy for gastric cancer: what have we learned since INT0116?Novel CD9-targeted therapies in gastric cancer Locally advanced gastroesophageal junction tumor: a treatment dilemma Comparison of international guidelines on the accompanying therapy for advanced gastric cancer: reasons for the differences Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review The current situation for gastric cancer in Chile Comparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer.Dose-dependent changes in renal (1)H-/(23)Na MRI after adjuvant radiochemotherapy for gastric cancer.Phase I study of postoperative radiotherapy combined with capecitabine for gastric cancer.Adjuvant chemoradiotherapy versus chemotherapy for gastric cancer: a meta-analysis of randomized controlled trials.Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series.Comments to young surgeons concerning laparoscopic spleen-preserving D2 lymph node dissection for advanced gastric cancer on the upper body.Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma.The significance of a nineteenth century definition in the era of genomics: linitis plastica.Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy.Evidence based radiation oncology with existing technology Towards personalized perioperative treatment for advanced gastric cancer.A phase II trial of post-operative chemoradiotherapy for completely resected gastric cancer with D2 lymphadenectomy Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: is radiotherapy necessary after D2-dissection?Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?Medical management of gastric cancer: a 2014 update.Adjuvant therapy for gastric cancer: current and future directions.Multimodality management of resectable gastric cancer: A review.Evaluation of prognostic factors and survival results in gastric carcinoma: single center experience from Northeast Turkey.Proton therapy in adjuvant treatment of gastric cancer: planning comparison with advanced x-ray therapy and feasibility report.Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.Outcome analysis of laporoscopic D1 and D2 dissection in patients 70 years and older with gastric cancer.

P2860

Q26738505-5E93BC4D-BBC6-4C2A-859B-CC895E50DECA Q26746147-5C42E511-C891-4A66-852F-E1D956A592F7 Q26748744-F3717CCF-AAAD-48CE-81E2-69541D689BE3 Q26771392-D8D5434E-7D0F-4218-8FC3-7C5F560AE955 Q26774521-F0AA5A6D-4740-4ED9-89D7-247F8860EF33 Q26774528-E2EEA753-3654-44F4-B7DC-E6780E14F932 Q26774533-90DB70B3-6C32-4EDC-8562-1459391CC672 Q26774538-3AB26F6A-007E-4BF7-A169-E24F772FD33F Q26774720-1B1EC230-C80B-48EE-91E5-722CD1D66970 Q26781043-D24D3080-8058-455B-85DC-5A5C73209096 Q26797427-880C34C3-DD5E-4F4D-B55A-43D8E972F238 Q26824863-750363E3-904F-4323-8B34-E079CBB4ADFF Q26858776-C36BE846-C78D-4543-82B4-A28123C831F5 Q27008675-7F548221-4120-435F-984A-2480DA591EB2 Q27026877-D28A467D-D3FE-486D-AD17-E82B38772DA8 Q28082596-9DFCBEFD-A417-4008-9909-FF85A676A210 Q28086772-3884A92C-25D2-4BC1-8B21-7E0FFD351431 Q28088619-7AD425D7-D80B-4C36-B082-1CBA87F0BF7E Q30238920-8641CA27-1914-4EA3-B32F-5D7E0CA84ECA Q30248541-2C1D8AF7-365E-44FF-83DA-7F2D4D4AB66E Q30872867-C34D78C7-8069-42E2-990A-338710A27642 Q33413548-27E9CF63-C90C-468E-8601-CB37C6096AE0 Q33417940-7872D079-D2D6-4C80-931B-C9EE3E152301 Q33650849-CA955EB7-7D51-45BB-9143-CADC81EE6BAC Q33827368-45DF3C51-EB77-4F02-96CF-B21C9016FAFF Q33831963-EC294AB0-6B16-45AF-99D2-90077996DD2D Q33876785-FE520873-7DB9-42CB-AA85-F69DB5809AA0 Q33889360-FEB4AD00-3722-434B-92BB-26CE63F087A1 Q33922185-F110DD76-40AB-4AC7-AD9D-6B431F7A5631 Q34137285-C49929EF-615B-48E3-997D-EA760EBA6606 Q34141623-41A7D11C-A22C-4A1B-AFE9-1CA0D80A81C1 Q34255467-23B475F5-37E1-4EE0-ADD1-3BF9F27E43F5 Q34278808-4EE76912-5EB5-41F4-8469-2C6C0D55A79B Q34326546-2EE3C086-E2AC-46CD-99FE-43A53CB14BF0 Q34326579-D07315E4-0F8C-4CE0-961C-F607937A6834 Q34340956-2A0EDCD8-517F-4A28-B2DC-E5C25A240483 Q34415003-92E5AE47-E1D0-40F7-8DA1-A2248CF533B9 Q34418908-0AE11BFB-E4DB-4C35-95BC-152922453834 Q34479911-D83BE391-9B2F-4712-80C3-3C9FD1A1966E Q34547604-945AA6CB-5B01-40BA-B0F7-F59C6E1149C2

P2860

Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.

http://www.wikidata.org/entity/Q34638268

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Updated analysis of SWOG-direc ...... tive gastric cancer resection.

@ast

Updated analysis of SWOG-direc ...... tive gastric cancer resection.

@en

Updated analysis of SWOG-direc ...... tive gastric cancer resection.

@nl

type

label

Updated analysis of SWOG-direc ...... tive gastric cancer resection.

@ast

Updated analysis of SWOG-direc ...... tive gastric cancer resection.

@en

Updated analysis of SWOG-direc ...... tive gastric cancer resection.

@nl

prefLabel

Updated analysis of SWOG-direc ...... tive gastric cancer resection.

@ast

Updated analysis of SWOG-direc ...... tive gastric cancer resection.

@en

Updated analysis of SWOG-direc ...... tive gastric cancer resection.

@nl

P1433

Q34638268-EC279E59-7A9B-44CD-8EFF-ACD5C246615E

P1476

Q34638268-B86EDF0F-027B-4C9E-ABB1-5BB975189142

P2093

Q34638268-14BA065B-BB8D-4EFF-A442-02960F56387F

Q34638268-20553526-6B32-4E8B-863E-38D347B9C4C8

Q34638268-42C7A7A3-0755-4D6C-BE0F-4ED7CCE4E95C

Q34638268-47937D26-AD36-4618-824B-DAB471EEAA6C

Q34638268-504BB992-FA1D-42E7-830A-F99625C5EFE7

Q34638268-59CFCD31-B65C-43AC-8FE1-F7A85BA0A2AB

Q34638268-6586464A-988C-4C18-AA14-A9DE2D4DD469

Q34638268-697760E8-BDB0-4572-8555-953759FA5ECD

Q34638268-A2D22D94-46B5-40A3-BEBA-9A7465B9AC4A

Q34638268-C6C344C8-AFAD-4ED5-9EA1-AE9727919497

P2860

Q34638268-0FB22B22-D39D-4EAB-95E2-2DF73FD4D088

Q34638268-13B6BC9E-045C-4CAB-A79D-ED5487C605EA

Q34638268-1441C2CD-5B13-46F4-9499-9F7F229E906A

Q34638268-195057E5-E898-41E6-87FF-CC6E8DBBB064

Q34638268-3907CCDF-0124-4F99-91B1-BF478EDDB06B

Q34638268-3CB7148A-5FD9-4808-B484-FDFD67A688CE

Q34638268-4BD25F98-516A-45F5-A7D1-2AA6FA70E899

Q34638268-4E484BB6-2EDA-492A-A802-E444DC78E432

Q34638268-521296A4-DEFD-4978-93AB-4AB9866EF42B

Q34638268-54F67881-8187-4BBE-87CB-E90963261A7A

P304

Q34638268-4327E8FD-74AC-4A53-A28F-40C93C317B3C

P31

Q34638268-BBAE1CD5-0DEE-4AC3-918A-83D746FDD2F4

P356

Q34638268-A70772BE-32F9-4FE2-A1D4-C3CFC8C5BC7A

P407

Q34638268-9F57F153-9F5D-4BF4-871D-496821370FBE

P433

Q34638268-4207504B-1EBB-4403-A9DB-CB8A96046BAC

P478

Q34638268-6127B214-D724-4486-91BB-69967D99E2D3

P577

Q34638268-0CDEEED6-F5B3-4FCC-8F48-A29CCFFF0B8F

P698

Q34638268-14C62F2C-A2AD-434F-9C82-88045E6917BD

P921

Q34638268-29BA9C1F-6AFE-48BE-93A8-99AF2A821C09

Q34638268-E096D452-15FB-445B-BB25-E6D3997E852D

P932

Q34638268-B7D1F416-D50B-4F09-89F2-259D3A156258

P356

JCO.2011.36.7136

P1433

Journal of Clinical Oncology

P1476

Updated analysis of SWOG-direc ...... tive gastric cancer resection.

@en

P2093

Bryan Goldman

http://www.w3.org/2001/XMLSchema#string

Charles D Blanke

http://www.w3.org/2001/XMLSchema#string

Daniel G Haller

http://www.w3.org/2001/XMLSchema#string

Grant N Stemmermann

http://www.w3.org/2001/XMLSchema#string

J Milburn Jessup

http://www.w3.org/2001/XMLSchema#string

Jacqueline K Benedetti

http://www.w3.org/2001/XMLSchema#string

Jaffer A Ajani

http://www.w3.org/2001/XMLSchema#string

James A Martenson

http://www.w3.org/2001/XMLSchema#string

John S Macdonald

http://www.w3.org/2001/XMLSchema#string

Leonard L Gunderson

http://www.w3.org/2001/XMLSchema#string

P2860

Neoadjuvant chemotherapy versus none for resectable gastric cancer

Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.

The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis.

The National Cancer Data Base report on gastric carcinoma.

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials.

Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

P304

2327-2333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2011.36.7136

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22585691

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

chemoradiotherapy

P932

4517071

http://www.w3.org/2001/XMLSchema#string